Loading…

NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain

► Both NTS1 and NTS2 are involved in mediating visceral analgesia. ► The role(s) of each NT receptor appear to be NT analog-dependent. ► NTS2 is necessary tolerance to NT69L-mediated visceral analgesia. ► NTS1 may inhibit NTS2-mediated analgesia. Neurotensin (NT) analogs, NT69L, NT72, and NT79, diff...

Full description

Saved in:
Bibliographic Details
Published in:Behavioural brain research 2012-06, Vol.232 (1), p.93-97
Main Authors: Smith, Kristin E., Boules, Mona, Williams, Katrina, Richelson, Elliott
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c386t-d97f4589561bde21a0e9e4cddb153a3c785c30caa83a6ff50bec0a68396c7fa93
cites cdi_FETCH-LOGICAL-c386t-d97f4589561bde21a0e9e4cddb153a3c785c30caa83a6ff50bec0a68396c7fa93
container_end_page 97
container_issue 1
container_start_page 93
container_title Behavioural brain research
container_volume 232
creator Smith, Kristin E.
Boules, Mona
Williams, Katrina
Richelson, Elliott
description ► Both NTS1 and NTS2 are involved in mediating visceral analgesia. ► The role(s) of each NT receptor appear to be NT analog-dependent. ► NTS2 is necessary tolerance to NT69L-mediated visceral analgesia. ► NTS1 may inhibit NTS2-mediated analgesia. Neurotensin (NT) analogs, NT69L, NT72, and NT79, differentially bind the two major neurotensin receptors, NTS1 and NTS2, to elicit effects similar to those of endogenous NT, including analgesia. Previous data strongly suggest NTS2 as the main receptor involved in NT- and NT analog-mediated visceral analgesia. However, this idea has yet to be confirmed with the use of mice lacking the NTS2 receptor. Here we use the writhing assay, a model of visceral pain, to investigate the analgesic effects of NT69L (binds NTS1 and NTS2 equally), NT79 (NTS2-selective), NT72 (NTS1 selective) and levocabastine (NTS2-selective) in WT, NTS1 knock-out, and NTS2 knock-out mice. Additionally, we investigate the role of NTS2 in the development of tolerance to NT69L-mediated visceral analgesia. All three NT analogs reduced writhing in the WT mice. NT79 and levocabsatine reduced writhing in the NTS1−/− mice while NT69L and NT72 showed significant analgesic effect in the NTS2−/− mice. In conclusion, the data shows that (1) both NTS1 and NTS2 are involved in mediating visceral analgesia and their respective roles appear to be NT analog-dependent; (2) NTS1 may inhibit NTS2-mediated analgesia; and (3) NTS2 is necessary for the development of tolerance to NT69L-mediated analgesia.
doi_str_mv 10.1016/j.bbr.2012.03.044
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1020846586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432812002495</els_id><sourcerecordid>1020846586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-d97f4589561bde21a0e9e4cddb153a3c785c30caa83a6ff50bec0a68396c7fa93</originalsourceid><addsrcrecordid>eNqNkc1O3DAUha2qVRmgD8AGedlNUv_HEasKQYuEYFFYWzfOzcijxBnsDFXfHk8HWFbd2Nb1d46uziHkjLOaM26-bequS7VgXNRM1kypD2TFbSOqRqv2I1kVxlRKCntEjnPeMMYU0_wzORJCM8WVXpFw9_CLU4g9LQ9BJ-wDLFgGMK4xB6DDPI7z7xDXNOIuzQvGHOLf_3lNl4SwTBgXup_Rad5lLGePY9El-hyyxwQj3UKIp-TTAGPGL6_3CXm8vnq4_Fnd3v-4ufx-W3lpzVL1bTMobVtteNej4MCwReX7vuNagvSN1V4yD2AlmGHQrEPPwFjZGt8M0MoT8vXgu03z0w7z4qb9GuMIEct-jjPBrDLamv9AeWO4sq0oKD-gPs05JxzcNoUJ0p8C7TnjNq6U4fZlOCZdKaNozl_td10J9l3xln4BLg4AljyeAyaXfcDoSwkJ_eL6OfzD_gV1s5o4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017614892</pqid></control><display><type>article</type><title>NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain</title><source>ScienceDirect Freedom Collection</source><creator>Smith, Kristin E. ; Boules, Mona ; Williams, Katrina ; Richelson, Elliott</creator><creatorcontrib>Smith, Kristin E. ; Boules, Mona ; Williams, Katrina ; Richelson, Elliott</creatorcontrib><description>► Both NTS1 and NTS2 are involved in mediating visceral analgesia. ► The role(s) of each NT receptor appear to be NT analog-dependent. ► NTS2 is necessary tolerance to NT69L-mediated visceral analgesia. ► NTS1 may inhibit NTS2-mediated analgesia. Neurotensin (NT) analogs, NT69L, NT72, and NT79, differentially bind the two major neurotensin receptors, NTS1 and NTS2, to elicit effects similar to those of endogenous NT, including analgesia. Previous data strongly suggest NTS2 as the main receptor involved in NT- and NT analog-mediated visceral analgesia. However, this idea has yet to be confirmed with the use of mice lacking the NTS2 receptor. Here we use the writhing assay, a model of visceral pain, to investigate the analgesic effects of NT69L (binds NTS1 and NTS2 equally), NT79 (NTS2-selective), NT72 (NTS1 selective) and levocabastine (NTS2-selective) in WT, NTS1 knock-out, and NTS2 knock-out mice. Additionally, we investigate the role of NTS2 in the development of tolerance to NT69L-mediated visceral analgesia. All three NT analogs reduced writhing in the WT mice. NT79 and levocabsatine reduced writhing in the NTS1−/− mice while NT69L and NT72 showed significant analgesic effect in the NTS2−/− mice. In conclusion, the data shows that (1) both NTS1 and NTS2 are involved in mediating visceral analgesia and their respective roles appear to be NT analog-dependent; (2) NTS1 may inhibit NTS2-mediated analgesia; and (3) NTS2 is necessary for the development of tolerance to NT69L-mediated analgesia.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2012.03.044</identifier><identifier>PMID: 22504145</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acetic Acid ; Analgesia ; Analgesics ; Analysis of Variance ; Animal models ; Animals ; Behavior, Animal - drug effects ; Data processing ; Histamine H1 Antagonists - pharmacology ; Mice ; Mice, Knockout ; Neurotensin ; Neurotensin - analogs &amp; derivatives ; Neurotensin - pharmacology ; neurotensin receptors ; NT69L ; NT72 ; NT79 ; Pain - drug therapy ; Pain - physiopathology ; Pain Measurement - drug effects ; Pain perception ; Peptide Fragments - pharmacology ; Piperidines - pharmacology ; Receptors, Neurotensin - genetics ; Receptors, Neurotensin - physiology ; Tolerance ; Writhing</subject><ispartof>Behavioural brain research, 2012-06, Vol.232 (1), p.93-97</ispartof><rights>2012 Elsevier B.V.</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-d97f4589561bde21a0e9e4cddb153a3c785c30caa83a6ff50bec0a68396c7fa93</citedby><cites>FETCH-LOGICAL-c386t-d97f4589561bde21a0e9e4cddb153a3c785c30caa83a6ff50bec0a68396c7fa93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22504145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Kristin E.</creatorcontrib><creatorcontrib>Boules, Mona</creatorcontrib><creatorcontrib>Williams, Katrina</creatorcontrib><creatorcontrib>Richelson, Elliott</creatorcontrib><title>NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>► Both NTS1 and NTS2 are involved in mediating visceral analgesia. ► The role(s) of each NT receptor appear to be NT analog-dependent. ► NTS2 is necessary tolerance to NT69L-mediated visceral analgesia. ► NTS1 may inhibit NTS2-mediated analgesia. Neurotensin (NT) analogs, NT69L, NT72, and NT79, differentially bind the two major neurotensin receptors, NTS1 and NTS2, to elicit effects similar to those of endogenous NT, including analgesia. Previous data strongly suggest NTS2 as the main receptor involved in NT- and NT analog-mediated visceral analgesia. However, this idea has yet to be confirmed with the use of mice lacking the NTS2 receptor. Here we use the writhing assay, a model of visceral pain, to investigate the analgesic effects of NT69L (binds NTS1 and NTS2 equally), NT79 (NTS2-selective), NT72 (NTS1 selective) and levocabastine (NTS2-selective) in WT, NTS1 knock-out, and NTS2 knock-out mice. Additionally, we investigate the role of NTS2 in the development of tolerance to NT69L-mediated visceral analgesia. All three NT analogs reduced writhing in the WT mice. NT79 and levocabsatine reduced writhing in the NTS1−/− mice while NT69L and NT72 showed significant analgesic effect in the NTS2−/− mice. In conclusion, the data shows that (1) both NTS1 and NTS2 are involved in mediating visceral analgesia and their respective roles appear to be NT analog-dependent; (2) NTS1 may inhibit NTS2-mediated analgesia; and (3) NTS2 is necessary for the development of tolerance to NT69L-mediated analgesia.</description><subject>Acetic Acid</subject><subject>Analgesia</subject><subject>Analgesics</subject><subject>Analysis of Variance</subject><subject>Animal models</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Data processing</subject><subject>Histamine H1 Antagonists - pharmacology</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Neurotensin</subject><subject>Neurotensin - analogs &amp; derivatives</subject><subject>Neurotensin - pharmacology</subject><subject>neurotensin receptors</subject><subject>NT69L</subject><subject>NT72</subject><subject>NT79</subject><subject>Pain - drug therapy</subject><subject>Pain - physiopathology</subject><subject>Pain Measurement - drug effects</subject><subject>Pain perception</subject><subject>Peptide Fragments - pharmacology</subject><subject>Piperidines - pharmacology</subject><subject>Receptors, Neurotensin - genetics</subject><subject>Receptors, Neurotensin - physiology</subject><subject>Tolerance</subject><subject>Writhing</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNkc1O3DAUha2qVRmgD8AGedlNUv_HEasKQYuEYFFYWzfOzcijxBnsDFXfHk8HWFbd2Nb1d46uziHkjLOaM26-bequS7VgXNRM1kypD2TFbSOqRqv2I1kVxlRKCntEjnPeMMYU0_wzORJCM8WVXpFw9_CLU4g9LQ9BJ-wDLFgGMK4xB6DDPI7z7xDXNOIuzQvGHOLf_3lNl4SwTBgXup_Rad5lLGePY9El-hyyxwQj3UKIp-TTAGPGL6_3CXm8vnq4_Fnd3v-4ufx-W3lpzVL1bTMobVtteNej4MCwReX7vuNagvSN1V4yD2AlmGHQrEPPwFjZGt8M0MoT8vXgu03z0w7z4qb9GuMIEct-jjPBrDLamv9AeWO4sq0oKD-gPs05JxzcNoUJ0p8C7TnjNq6U4fZlOCZdKaNozl_td10J9l3xln4BLg4AljyeAyaXfcDoSwkJ_eL6OfzD_gV1s5o4</recordid><startdate>20120615</startdate><enddate>20120615</enddate><creator>Smith, Kristin E.</creator><creator>Boules, Mona</creator><creator>Williams, Katrina</creator><creator>Richelson, Elliott</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QG</scope><scope>7TK</scope></search><sort><creationdate>20120615</creationdate><title>NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain</title><author>Smith, Kristin E. ; Boules, Mona ; Williams, Katrina ; Richelson, Elliott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-d97f4589561bde21a0e9e4cddb153a3c785c30caa83a6ff50bec0a68396c7fa93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acetic Acid</topic><topic>Analgesia</topic><topic>Analgesics</topic><topic>Analysis of Variance</topic><topic>Animal models</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Data processing</topic><topic>Histamine H1 Antagonists - pharmacology</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Neurotensin</topic><topic>Neurotensin - analogs &amp; derivatives</topic><topic>Neurotensin - pharmacology</topic><topic>neurotensin receptors</topic><topic>NT69L</topic><topic>NT72</topic><topic>NT79</topic><topic>Pain - drug therapy</topic><topic>Pain - physiopathology</topic><topic>Pain Measurement - drug effects</topic><topic>Pain perception</topic><topic>Peptide Fragments - pharmacology</topic><topic>Piperidines - pharmacology</topic><topic>Receptors, Neurotensin - genetics</topic><topic>Receptors, Neurotensin - physiology</topic><topic>Tolerance</topic><topic>Writhing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Kristin E.</creatorcontrib><creatorcontrib>Boules, Mona</creatorcontrib><creatorcontrib>Williams, Katrina</creatorcontrib><creatorcontrib>Richelson, Elliott</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Kristin E.</au><au>Boules, Mona</au><au>Williams, Katrina</au><au>Richelson, Elliott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>2012-06-15</date><risdate>2012</risdate><volume>232</volume><issue>1</issue><spage>93</spage><epage>97</epage><pages>93-97</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><abstract>► Both NTS1 and NTS2 are involved in mediating visceral analgesia. ► The role(s) of each NT receptor appear to be NT analog-dependent. ► NTS2 is necessary tolerance to NT69L-mediated visceral analgesia. ► NTS1 may inhibit NTS2-mediated analgesia. Neurotensin (NT) analogs, NT69L, NT72, and NT79, differentially bind the two major neurotensin receptors, NTS1 and NTS2, to elicit effects similar to those of endogenous NT, including analgesia. Previous data strongly suggest NTS2 as the main receptor involved in NT- and NT analog-mediated visceral analgesia. However, this idea has yet to be confirmed with the use of mice lacking the NTS2 receptor. Here we use the writhing assay, a model of visceral pain, to investigate the analgesic effects of NT69L (binds NTS1 and NTS2 equally), NT79 (NTS2-selective), NT72 (NTS1 selective) and levocabastine (NTS2-selective) in WT, NTS1 knock-out, and NTS2 knock-out mice. Additionally, we investigate the role of NTS2 in the development of tolerance to NT69L-mediated visceral analgesia. All three NT analogs reduced writhing in the WT mice. NT79 and levocabsatine reduced writhing in the NTS1−/− mice while NT69L and NT72 showed significant analgesic effect in the NTS2−/− mice. In conclusion, the data shows that (1) both NTS1 and NTS2 are involved in mediating visceral analgesia and their respective roles appear to be NT analog-dependent; (2) NTS1 may inhibit NTS2-mediated analgesia; and (3) NTS2 is necessary for the development of tolerance to NT69L-mediated analgesia.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>22504145</pmid><doi>10.1016/j.bbr.2012.03.044</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0166-4328
ispartof Behavioural brain research, 2012-06, Vol.232 (1), p.93-97
issn 0166-4328
1872-7549
language eng
recordid cdi_proquest_miscellaneous_1020846586
source ScienceDirect Freedom Collection
subjects Acetic Acid
Analgesia
Analgesics
Analysis of Variance
Animal models
Animals
Behavior, Animal - drug effects
Data processing
Histamine H1 Antagonists - pharmacology
Mice
Mice, Knockout
Neurotensin
Neurotensin - analogs & derivatives
Neurotensin - pharmacology
neurotensin receptors
NT69L
NT72
NT79
Pain - drug therapy
Pain - physiopathology
Pain Measurement - drug effects
Pain perception
Peptide Fragments - pharmacology
Piperidines - pharmacology
Receptors, Neurotensin - genetics
Receptors, Neurotensin - physiology
Tolerance
Writhing
title NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A52%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NTS1%20and%20NTS2%20mediate%20analgesia%20following%20neurotensin%20analog%20treatment%20in%20a%20mouse%20model%20for%20visceral%20pain&rft.jtitle=Behavioural%20brain%20research&rft.au=Smith,%20Kristin%20E.&rft.date=2012-06-15&rft.volume=232&rft.issue=1&rft.spage=93&rft.epage=97&rft.pages=93-97&rft.issn=0166-4328&rft.eissn=1872-7549&rft_id=info:doi/10.1016/j.bbr.2012.03.044&rft_dat=%3Cproquest_cross%3E1020846586%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c386t-d97f4589561bde21a0e9e4cddb153a3c785c30caa83a6ff50bec0a68396c7fa93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1017614892&rft_id=info:pmid/22504145&rfr_iscdi=true